All signals GO! Leipzig has launched construction on its centrally-located Innovation Center which is slated to open in 2026.
50 million Euros to expand Institute for Drug Development
After just receiving almost 2 million dollars in funding to establish a digital ‘vaccine library’, Leipzig University’s Institute for Drug Development is celebrating its next windfall.
New vaccine library set to revolutionize pandemic prevention
Upcoming viral threats need a fast response to prevent future pandemics. That’s why Leipzig University is now establishing a digital ‘vaccine library’ so that researchers and clinicians can quickly develop effective vaccines in these situations.
Preclinical and clinical development
Preclinical and clinical development of a novel CAR-T cell therapy for the treatment of multiple myeloma and clear cell renal cell carcinoma.
Exciting new research project: 6G Health launches in Leipzig
Imagine that a top surgeon could help operate on you from 100 km away. Science fiction? Not in Leipzig!
Global run on MEDICAL FORGE Leipzig
Think ‘Shark Tank’ for the medical industry: #kiddingnotkidding.
CityLab Leipzig: prime location for life science companies
As a renter, you want a flexible setup and good neighbors. That’s why future life science industry tenants of CCL CityLab Leipzig can count themselves lucky
Heartfelt help for kids and their families
Children’s hospice Bärenherz Leipzig e.V. relies on external funds to help kids and their families.
Impressions BIO-Europe 2022
As co-hosts, we are proud to share that the biotech partnering event BIO-Europe 2022 broke all records. We welcomed more than 5,000 guests from 66 countries here in Leipzig! Were you there to see us make the leap into the Champions League of life science locations in Europe? Click below to enjoy our gallery of pictures from the event.
First in Europe: All approved CAR-T cell therapy products are available at the University Hospital Leipzig (UKL).
Chimeric Antigen Receptor T Cell Therapy (CAR-T): Genetically programmed immune cell binds to and destroys cancer cell / Therapy is now available for the majority of indications